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Abstract
Background: The National Institute for Health Research (NIHR) has funded nine Collaborations for Leadership in 
Applied Health Research and Care (CLAHRCs). Each CLAHRC is a partnership between higher education institutions 
(HEIs) and the NHS in nine UK regional health economies. The CLAHRC for Leeds, York, and Bradford comprises two 
'research themes' and three 'implementation themes.' One of these implementation themes is Translating Research 
into Practice in Leeds and Bradford (TRiPLaB). TRiPLaB aims to develop, implement, and evaluate methods for inducing 
and sustaining the uptake of research knowledge into practice in order to improve the quality of health services for the 
people of Leeds and Bradford.
Methods: TRiPLaB is built around a three-stage, sequential, approach using separate, longitudinal case studies 
conducted with collaborating NHS organisations, TRiPLaB will select robust innovations to implement, conduct a 
theory-informed exploration of the local context using a variety of data collection and analytic methods, and 
synthesise the information collected to identify the key factors influencing the uptake and adoption of targeted 
innovations. This synthesis will inform the development of tailored, multifaceted, interventions designed to increase 
the translation of research findings into practice. Mixed research methods, including time series analysis, quasi-
experimental comparison, and qualitative process evaluation, will be used to evaluate the impact of the 
implementation strategies deployed.
Conclusion: TRiPLaB is a theory-informed, systematic, mixed methods approach to developing and evaluating tailored 
implementation strategies aimed at increasing the translation of research-based findings into practice in one UK health 
economy. Through active collaboration with its local NHS, TRiPLaB aims to improve the quality of health services for the 
people of Leeds and Bradford and to contribute to research knowledge regarding the interaction between context and 
adoption behaviour in health services.
Background
In response to the recommendation of the Chief Medical
Officer's Clinical Effectiveness Group that the NHS
should better utilise higher education to support initia-
tives to enhance the effectiveness and efficiency of clini-
cal care [1], the National Institute for Health Research
(NIHR) announced a strategy of increasing partnerships
between higher education and the NHS in local health
economies. One means of developing these partnerships
is Collaborations in Leadership and Applied Health
Research and Care or CLAHRCs. The NIHR has funded
nine CLAHRCs, each with an emphasis on research that
makes an impact locally and with a strong, disciplined,
and strategic approach to implementing that research.
The NIHR CLAHRC for Leeds, York and Bradford
(LYBRA) comprises two 'research' programmes (Improv-
ing Vascular Prevention in Cardiac and Stroke Care
(IMPROVE-PC), Improving the Quantity and Quality of
Life in People with Addictions) and three 'implementa-
tion' programmes (Outcome Driven Stroke Care, Mater-
nal and Child Health, and the focus of this protocol,
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Translating Research into Practice in Leeds and Bradford,
or TRiPLaB).
The aim of TRiPLaB is to develop, implement, and
evaluate methods of inducing and sustaining the uptake
of research into practice in order to improve the quality
of health services for the people of Leeds and Bradford.
Research implementation is a complex process, highly
dependent on context, and interactions between multi-
ple, interconnected, factors at the level of individuals,
groups, organisations and wider health systems [2-6].
Despite this complexity, or perhaps because of it, imple-
mentation research has often focused on individual
behaviour change without reflecting on, or paying atten-
tion to, the characteristics of health technologies, the
processes by which health technologies are adopted and
sustained, or a workable understanding of the particular
context in which implementation occurs [7].
Successive reviews of the evidence for successful trans-
lation of research findings into healthcare practice reveal
that a range of implementation strategies can be success-
ful. However, why strategies work in some circumstances
but not others remains unclear [3,6,8].
Using theory to guide the exploration of the local con-
text for implementation can help [6]. First, relevant theo-
ries enable the tailoring of strategies to the most
significant barriers to translating research into practice in
a given context. Second, theories enable researchers to
build on existing knowledge and increase the transferabil-
ity of findings to settings and contexts other than the
immediate research environment [9].
TRiPLaB will use theory to guide its exploration of con-
text in our collaborating healthcare organisations. This
exploration will in turn inform the development of tai-
lored implementation strategies for innovation delivery.
The synthesis of research findings by Greenhalgh et al.
[5] on the dissemination and implementation of research-
based innovations provides the theoretical framework for
TRiPLaB. Their analysis proposes that successful innova-
tion adoption requires analysis of the characteristics of
the innovation itself, the perceptions of those individuals
tasked with adopting the innovation, and the wider
organisational cultures in place in the setting for adop-
tion. Shaped by diffusion of innovation theory [10],
Greenhalgh et al. also acknowledge the influence of chan-
nels of communication, or social networks, between
practitioners as important influences on whether, and
how quickly, an innovation is adopted. In adopting this
particular theoretical framework, TRiPLaB will explore
the relative influence of these often overlooked but
important elements at individual, team and organisa-
tional levels in our NHS partners [2-6]. This theory-
informed exploration will form our 'diagnostic analysis'
[3] of the local context in each of the NHS healthcare
organisations that make up our case study series.
Methods
Ethical approval for this study was given by York
Research Ethics Committee (REC 10/H1311/1).
The Develop, IMplement, Evaluate (DIME) approach of 
TRiPLaB
TRiPLaB is a multisite, longitudinal, mixed methods case
study. Currently, we are working with NHS Bradford and
Airedale (an NHS commissioning and community pro-
vider organisation) to translate research-based findings
into practice in the areas of maternal mental health and
stroke care, and with Leeds Partnership Foundation Trust
(a provider of mental health services) to enhance the
implementation of recent and relevant NICE guidance.
Each case study will have three sequential phases (see
Figure 1): the findings from the development phase
(phase one) lead into the implementation phase (phase
two), and the outcomes of this are assessed in the evalua-
tion phase (phase three). The three-phase approach has
been informed by the Medical Research Council's frame-
work [11] for developing and evaluating complex inter-
ventions, acknowledges the need to use theory in
planning and analysis, recognises the importance of local
context, piloting, and evaluating intervention compo-
nents, and the use of multiple outcome measures to eval-
uate intervention effectiveness. The three phases are
summarised below.
Phase one is a development phase in which the innova-
tion that is the focus of each case study will be selected
and its key characteristics mapped. Theory-informed fac-
tors hypothesised as influential in health professionals'
adoption of the selected innovation into routine practice
are explored and mapped.
Phase two is an implementation phase in which tailored
behaviour-change interventions are developed piloted
and delivered using personnel from TRiPLaB and its
partner organisations.
Phase Three is an evaluation phase in which changes in
structure, process, and outcome are described and evalu-
a t e d .  W e  w i l l  b e  l o o k i n g  a t  c h a n g e  b o t h  w i t h i n  a n d ,
towards the end of the programme, between case studies.
TRiPLaB will use the resources of the Centre for
Reviews and Dissemination (CRD) to increase the acces-
sibility of research evidence to decision makers (particu-
larly commissioners) in the NHS. Primarily, we will do
this by using tailored briefings relating research evidence
to specific decision problems and context in Bradford and
Leeds. These 'evidence briefings' will be based on existing
sources of synthesised and quality assessed evidence - for
example, CRD's databases of systematic reviews (DARE)
and economic evaluations (NHS EED). We will develop
and implement methods for producing and disseminating
evidence briefings and evaluate their perceived useful-
ness, costs, and use by decision makers.Hanbury et al. Implementation Science 2010, 5:37
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Development phase (phase one)
Selecting the innovation
At the start of each case study, the specific innovation to
be targeted will be selected. The selection will be based
on the results of: a qualitative stakeholder consultation
designed to identify key topics; a conjoint analysis survey
of commissioners and practitioners designed to explore
those characteristics of innovations likely to influence
individuals' prioritisation of them; and a mapping exer-
cise exploring how each of the stakeholder short-listed
topics 'scores' against the characteristics measured in the
conjoint analysis survey (for example, local capacity and
expertise for implementation, cost/impact on local bud-
gets). We will also consider pragmatic issues, such as the
presence or absence of routine data sources to aid the
measurement of innovation adoption.
Stakeholder consultations will focus on identifying key
topics in the relevant clinical area. For example, in NHS
Bradford and Airedale, stakeholder consultation in the
area of child and maternal health care with a range of
commissioners and practitioners revealed the impor-
tance of maternal mental health as a focus for activity.
The conjoint survey will reveal the characteristics [6]
that influence an individual's decision to prioritise one
innovation over another. The factors that make up the
conjoint profiles to be evaluated will include characteris-
t i c s  s u c h  a s  t h e  s t r e n g t h  o f  s u p p o r t i n g  e v i d e n c e  b a s e
behind an innovation and its economic costs. By conjoint
analysing the characteristics of potential innovations, we
will be able to 'plug in' future innovations and inform the
organisation's understanding the likelihood of successful
implementation. This has the obvious advantage of not
having to ask the healthcare workforce or consumers to
rank or rate innovations on multiple occasions. The con-
joint analysis also reduces the likelihood of the TRiPLaB
team targeting respondents (for example, as change
agents) who may not favour the innovation eventually
selected.
The mapping exercise will score short-listed innova-
tions against characteristics measured in the conjoint
analysis survey. For example, the strength of supporting
evidence base for each of the short listed innovations
from the stakeholder consultation will be explored
through reference to published systematic reviews. The
outcome of this process will be summarised in a matrix.
Finally, the pragmatic factors to be considered will
include whether suitable process of care and health out-
come measures are available through routinely collected
data to evaluate the impact of the implementation strate-
gies, or whether tailor-made, repeatable, audits have to be
established.
Figure 1 The Develop, Implement, Evaluate model of TRiPLaB.
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The selected innovation for each case study will be one
that has been identified as a key topic from the stake-
holder consultation that scores highly on those character-
i s t i c s  i d e n t i f i e d  f r o m  t h e  c o n j o i n t  a n a l y s i s  s u r v e y  a s
influential in commissioners' and practitioners' prioritisa-
tion of innovations, and can be monitored through tailor-
made audits or, preferably, via routinely collected data. In
sum, the combination of stakeholder consultation, the
conjoint survey of practitioner and commissioner prefer-
ences, and the mapping exercise will enable us to select a
robust but feasible innovation to target in each case site.
Exploring the local context
Following selection of the innovation to be targeted, we
will undertake a diagnostic analysis [3] in which we will
administer a second survey in each case site to measure
health professionals' attitudes towards the innovation,
health care team innovation culture (using the Team Cli-
mate Inventory [12]), and the social networks/communi-
cation channels between health professionals with
regards to the innovation. A series of semi-structured
interviews will also be conducted with a sample of the
health professionals to further explore perceived barriers
to implementation, and to gain a richer understanding of
the influence of health care teams and social networks in
the uptake and adoption of new innovations into practice.
Quantitative survey data will be synthesised using mul-
tilevel modelling (MLM) approaches to identify the hier-
archical level most likely to be responsive to the
implementation strategies developed. For example, if the
MLM identifies healthcare team culture to be particularly
influential, a multifaceted intervention specifically target-
ing a team's culture towards innovation might (a priori)
be more successful than an intervention targeting only
individual attitudes towards the innovation. This focus is
deliberate given the current dearth of implementation
research examining the influence of factors at different
hierarchical levels in the health care system, and recom-
mendations for further research in this area [13]. The
qualitative data collected from the semi-structured inter-
views will be analysed using thematic analysis and com-
bined with the outcome of the MLM to gain a richer
understanding of the local context and to help tailor the
implementation strategies.
Implementation phase (phase two)
Development of the intervention will be systematic, spec-
ifying intervention objectives, developing specific imple-
mentation strategies to satisfy these objectives, and
piloting strategies to assess their likely impact and test
h o w  t h e y  w i l l  b e  r e c e i v e d  b y  t h e  h e a l t h  p r o f e s s i o n a l s .
This piloting and modelling prior to rolling out imple-
mentation strategies/behaviour-change interventions is a
necessary prerequisite stage [11]. The objectives and
design of the intervention will be determined by the out-
come of the development phase, in particular the results
of the planned multilevel modelling. The selection and
design of the actual intervention components will be
informed by existing systematic, and other, reviews of the
relevant literature.
Having decided on the innovation in phase one and
possible implementation strategies in phase two, we will
make the final choice on our implementation approach
with reference to the idea of 'policy' cost effectiveness
[14]. Summary data on: the innovation from Phase One
(net cost per patient and likely health gain per patient);
the implementation strategies under consideration (net
cost of planned implementation and likely change in
adoption/adherence); and local scale factors (for example,
the number of NHS organisational units involved and
number of patients targeted) will be combined to arrive at
a policy cost effectiveness figure for each option. The
combination with the highest cost effectiveness will be
the option pursued.
The failure to adequately describe interventions in the
context of research and the commensurate reduction in
others' ability to then use successful programs -- or con-
versely, avoid making the same mistakes as unsuccessful
ones -- is common in healthcare research [15]. For each
of the case studies in the TRiPLaB program we will
describe: the intervention and its component parts in suf-
ficient detail that others could reproduce it; why the spe-
cific intervention was chosen; and a fidelity measure of
how well the intervention was delivered. For example, if
we undertake educational outreach or training as a com-
ponent of an intervention, we will detail how many ses-
sions each unit of analysis receive, and when and where
the training took place.
Evaluation phase (phase three)
Following the recommendation to conduct exploratory
trials prior to embarking on more definitive randomised
controlled trials [11], TRiPLaB will employ three different
methods to evaluate the impact of the tailored implemen-
tation strategies delivered in each case study. The find-
ings from these evaluation measures will inform (if
worthwhile) later randomised controlled trials. The three
methods to be used are: interrupted time series analysis
of either tailor-made audit data or routinely collected
data to estimate the impact of the intervention upon suit-
able process of care and outcome measures; comparison
of pre- and post-intervention scores of survey-gathered
measures of individual attitudes, team culture, and
changing nature, composition, and size of social net-
works; and a qualitative process evaluation of why the
intervention worked (or did not work).
Alongside these three primary evaluation methods we
will also collect cost data on the resources used in the
delivery of implementation approaches. The micro costsHanbury et al. Implementation Science 2010, 5:37
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[16] associated with each strategy will be estimated
alongside the extent of behavioural change achieved to
arrive at summary estimates of implementation cost
effectiveness [14] for each of the case studies in the pro-
gramme.
Interrupted time series analysis
Interrupted time series designs compare multiple 'before
and after' (the introduction of a change strategy) mea-
sures to detect whether an intervention has had an effect
over and above any underlying trend in the data [17].
T i m e  s e r i e s  a n a l y s i s  h a s  b e e n  u s e d  a s  a  t e c h n i q u e  f o r
evaluating the effectiveness of health care interventions
[18]. In the case studies, routinely collected process
(health professionals' adoption of the innovation) and
health outcome measures (dependent on the innovation
selected) will provide the multiple time points necessary
to perform a time series analysis. Time, possible seasonal
trend, and possible upward trend, commonly occurring
following the introduction of a new innovation [10], will
be modelled into the analysis. This will be the primary
outcome measure for each case study.
Comparison of pre- and post-intervention scores
The interrupted time series analysis will estimate the
impact of the intervention upon process of care and
health outcome measures; however, a comparison of pre-
and post-intervention scores is also necessary to estimate
whether the intervention successfully changed the factors
(for example, individual attitudes, social networks and
team culture) in the underlying theoretical framework
that it was designed to target (based on the data synthesis
through multilevel modelling in TRiPLaB's development
phase in each site). This 'meditational analysis' [9] is criti-
cal when evaluating the theory used to develop change
interventions, as it will inform our understanding of why
an intervention either works or fails to work in the ways
we intended.
Qualitative process evaluation
Qualitative interviews with health professionals receiving
the intervention will enable an exploration of their per-
ceptions of what worked and what did not work in the
intervention, providing insight into the 'black box' of
intervention effectiveness [19]. In combination with the
measure of fidelity taken during the implementation
phase, these qualitative interviews comprise a process
evaluation of the intervention, addressing recommenda-
tions to monitor intervention delivery and receipt by par-
ticipants [11,20]. The data will be analysed using a
framework approach [21]: familiarisation with the data,
identification of a thematic framework, indexing, chart-
ing, and finally, mapping and interpretation with refer-
ence to the overall aim of TRiPLaB as well as the themes
revealed by the data.
Conclusion
TRiPLaB is a theory-informed, systematic, mixed meth-
ods approach to developing and evaluating tailored
implementation strategies aimed at increasing the trans-
lation of research findings into clinical and service prac-
tice. TRiPLaB aims to play a part in improving the quality
of health services for the people of Leeds and Bradford.
By working alongside multiple healthcare organisations
in a series of longitudinal case studies, the TRiPLaB pro-
gramme will develop a richer understanding of key issues
influencing the adoption of innovations in the NHS and
the promotion of quality improvement in routine prac-
tice.
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